MedicalResearch.com Interview with:
Anil K. Sood MD
Department of Gynecologic Oncology
The University of Texas MD Anderson Cancer Center
Unit 1362, PO Box 301439, Houston, TX, 77030
MedicalResearch.com: What are the main findings of the study?
Dr. Sood: For women with newly diagnosed
ovarian cancer, high heart rate at diagnosis (tachycardia), venous thromboembolism (VTE) occurring after diagnosis and pulmonary hypertension post-diagnosis are independently related to reduced survival after controlling for tumor stage, grade, and extent of cytoreduction. Women with tachycardia lived an average of 4.0 years after diagnosis compared with 5.9 years for women without tachycardia, a 32% reduction in duration of survival. Patients who experienced
VTE lived a median 4.1 years after diagnosis, compared with 6.4 yrs for patients who did not experience VTE.